GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.11
Bid: 0.10
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.02 (20.00%)
Open: 0.11
High: 0.11
Low: 0.11
Prev. Close: 0.11
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

23 Dec 2013 13:40

RNS Number : 2475W
Deltex Medical Group PLC
23 December 2013
 
Deltex Medical Group plc

 

Directors' Shareholdings/Issue of equity

 

 

23 December 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 790,574 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 14.00 pence per share.

 

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 October 2012 to 31 December 2013.

 

Paul Mitchell, Finance Director has elected to take New Ordinary Shares in lieu of £20,000 of salary in respect of the period 1 January 2013 to 31 December 2013.

 

In addition to the above, the Company also announces that it has today issued a total of 71,429 New Ordinary Shares to a former employee of the Company at a price of 14.00 pence per share in settlement of contractual obligations.

 

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 31 December 2013. Following the issue of these new shares the Company has a total of 168,070,379 ordinary shares of 1p each in issue.

 

Following this issue, the directors' beneficial interests are as follows:

 

 

Name of Director

Number of New Ordinary Shares issued in lieu of fees/salary

 

Holding of shares following issue of New Ordinary Shares

 

% of enlarged issued share capital

Nigel Keen

297,616

6,985,163

4.16

Dr Edwin Snape

214,286

1,430,624

0.85

Sir Duncan Nichol

75,000

928,916

0.55

Julian Cazalet

49,386

4,080,268

2.43

Paul Mitchell

82,857

352,831

0.21

 

For further information:

 

Deltex Medical Group plc

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman

 

Ewan Phillips, Chief Executive

 

Paul Mitchell, Finance Director

 

 

 

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

Financial Public Relations

Newgate Threadneedle

020 7653 9850

Graham Herring

Caroline Evans-Jones

Heather Armstrong

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEIFDDFDSEDE
Date   Source Headline
22nd Apr 200812:10 pmRNSHolding(s) in Company
18th Apr 20087:00 amRNSCompletion of Funding Package
15th Apr 20087:01 amRNSCardioQ update
14th Apr 20087:01 amRNSCardioQ update
7th Apr 20087:01 amRNSFinal Results
7th Apr 20087:01 amRNSNew Non-Executive Director
3rd Apr 20087:00 amRNSCardioQ update
2nd Apr 20087:01 amRNSCardioQ update
28th Mar 20087:02 amRNSNTAH update
26th Mar 20087:02 amRNSCardioQ update
20th Mar 20087:00 amRNSNotice of Results
3rd Mar 20083:22 pmRNSODM meta - analysis
25th Jan 20083:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20087:01 amRNSPositive Scientific Review
23rd Jan 20087:01 amRNSPre-close update
18th Jan 200811:41 amRNSHSJ Article
26th Nov 20079:03 amRNSDirector/PDMR Shareholding
21st Nov 20077:02 amRNSCardioQ Product Endorsement
31st Oct 20072:15 pmRNSTotal Voting Rights
22nd Oct 20079:01 amRNSHolding(s) in Company
16th Oct 20074:03 pmRNSAdditional Listing
1st Oct 20077:06 amRNSCardioQ announcement
25th Sep 200711:00 amRNSInterim Results - Replacement
25th Sep 20077:03 amRNSInterim Results
16th Aug 20073:53 pmRNSAIM Rule 26 Information
31st Jul 20073:29 pmRNSTotal Voting Rights
25th Jul 200711:30 amRNSRecommendation for CardioQ
11th Jul 20077:01 amRNSTrading Statement
5th Jul 20073:30 pmRNSImproving Surgical Outcomes
29th Jun 20073:34 pmRNSDirector/PDMR Shareholding
29th Jun 20073:26 pmRNSAdditional Listing
29th Jun 20078:52 amRNSTotal Voting Rights
28th Jun 20077:04 amRNSNew Clinical Evidence
22nd Jun 20077:01 amRNSAdditional Listing
19th Jun 20073:02 pmRNSHolding(s) in Company
14th Jun 20074:02 pmRNSAdditional Listing
7th Jun 20077:03 amRNSNew CardioQ Data
5th Jun 20077:02 amRNSUS Reimbursement Update
31st May 20078:49 amRNSTotal Voting Rights
23rd May 20077:32 amRNSUS Reimbursement Coverage
22nd May 20078:31 amRNSAdditional Listing
3rd May 20071:06 pmRNSIssue of Equity
3rd May 200710:25 amRNSAGM Statement
12th Apr 20077:01 amRNSUCLH adopts CardioQ
28th Mar 20078:00 amRNSHealth Technology Assessment
21st Mar 20072:53 pmRNSHolding(s) in Company
15th Mar 20077:05 amRNSUS Government HTA Published
15th Mar 20077:01 amRNSFinal Results
9th Mar 200712:35 pmRNSHolding(s) in Company
2nd Mar 20073:56 pmRNSDeltex SupraQ Demo Invite

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.